Federal Regulators Issue Warning Letter to Teva Pharmaceuticals
Teva Pharmaceuticals just received a “Warning Letter” from the U.S. Food and Drug Administration (FDA) due to the agency’s Current Good Manufacturing Practices (CGMP) inspection of Teva’s Gödöllő, Hungary’s manufacturing facility. Teva was also placed on Import Alert 66-40 on May 27, 2016. The agency’s warning letter notes … [Read more...] about Federal Regulators Issue Warning Letter to Teva Pharmaceuticals
Teva Pharmaceuticals Warning Letter from FDA
FDA Sent Warning Letter To Teva Pharmaceuticals Industries. The U.S. Food and Drug Administration (FDA) has sent a warning letter to Teva Pharmaceutical Industries Ltd on October 14, 2016. The warning letter is associated with an FDA Current Good Manufacturing Practices (CGMP) inspection of Teva's manufacturing facility. The FDA … [Read more...] about Teva Pharmaceuticals Warning Letter from FDA
Teva Pharmaceuticals Initiates Voluntary Recall due to Potential Glass Particulate Matter
Teva Pharmaceuticals based in North Wales, Pennsylvania, announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL and 1 tram/4mL vials as a result of the potential presence of glass particulate matter. Amikacin Sulfate Injection is used in the short-term treatment of serious infection due to strains … [Read more...] about Teva Pharmaceuticals Initiates Voluntary Recall due to Potential Glass Particulate Matter
